You might know you need to conduct drug metabolism and pharmacokinetic (DMPK) analysis, but which tests are right for your project? And are you doing them at the right time? When building your preclinical strategy, these questions matter—and that’s true now more than ever, as new drug classes and targets emerge.
September 30, 2020
- Using Flow Cytometry to Characterize Myeloid Derived Suppressor Cells (MDSC)
- Measuring Innate Immune/Phagocytic Cell Function by Flow Cytometry
- Immunophenotyping Pig Immune Cells by Flow Cytometry
- The Thing About Theranostics…
- American Association of Pharmaceutical Scientists (AAPS) Flow Cytometry Action Programming Committee
Using Flow Cytometry to Characterize Myeloid Derived Suppressor Cells (MDSC)
By Darcey L. Clark, MS DABT, Senior Biotechnology Professional
Measuring Innate Immune/Phagocytic Cell Function by Flow Cytometry
By Darcey L. Clark, MS DABT, Senior Biotechnology Professional
Immunophenotyping Pig Immune Cells by Flow Cytometry
By Jennifer J. Stewart, PhD
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.
